Literature DB >> 25445533

Administration strategies for proteins and peptides.

D Ibraheem1, A Elaissari1, H Fessi2.   

Abstract

Proteins are a vital constituent of the body as they perform many of its major physiological and biological processes. Recently, proteins and peptides have attracted much attention as potential treatments for various dangerous and traditionally incurable diseases such as cancer, AIDS, dwarfism and autoimmune disorders. Furthermore, proteins could be used for diagnostics. At present, most therapeutic proteins are administered via parenteral routes that have many drawbacks, for example, they are painful, expensive and may cause toxicity. Finding more effective, easier and safer alternative routes for administering proteins and peptides is the key to therapeutic and commercial success. In this context, much research has been focused on non-invasive routes such as nasal, pulmonary, oral, ocular, and rectal for administering proteins and peptides. Unfortunately, the widespread use of proteins and peptides as drugs is still faced by many obstacles such as low bioavailability, short half-life in the blood stream, in vivo instability and numerous other problems. In order to overcome these hurdled and improve protein/peptide drug efficacy, various strategies have been developed such as permeability enhancement, enzyme inhibition, protein structure modification and protection by encapsulation. This review provides a detailed description of all the previous points in order to highlight the importance and potential of proteins and peptides as drugs.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Administration routes; Bioavailability; Encapsulation; Immunotherapy; Peptides; Protein

Mesh:

Substances:

Year:  2014        PMID: 25445533     DOI: 10.1016/j.ijpharm.2014.10.059

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  17 in total

Review 1.  Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities.

Authors:  Vibhuti Agrahari; Vivek Agrahari; Ashim K Mitra
Journal:  Ther Deliv       Date:  2016

2.  Design of Insulin-Loaded Nanoparticles Enabled by Multistep Control of Nanoprecipitation and Zinc Chelation.

Authors:  Sunandini Chopra; Nicolas Bertrand; Jong-Min Lim; Amy Wang; Omid C Farokhzad; Rohit Karnik
Journal:  ACS Appl Mater Interfaces       Date:  2017-03-21       Impact factor: 9.229

Review 3.  Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome.

Authors:  Yonghyun Lee; Nobuhiko Kamada; James J Moon
Journal:  Adv Drug Deliv Rev       Date:  2021-10-26       Impact factor: 15.470

4.  Investigating the stabilisation of IFN-α2a by replica exchange molecular dynamics simulation.

Authors:  Daixi Li; Peiqin Chen; Qingli Dong; Baolin Liu; Wujie Zhang; Dong-Qing Wei; Baisong Guo
Journal:  J Mol Model       Date:  2022-07-26       Impact factor: 2.172

5.  Toxicity Profiling of Bacterial Inclusion Bodies in Human Caco-2 Cells.

Authors:  Irene Barguilla; Ugutz Unzueta; Jose Vicente Carratalá; Olivia Cano-Garrido; Antonio Villaverde; Alba Hernández; Neus Ferrer-Miralles
Journal:  Front Bioeng Biotechnol       Date:  2022-04-29

Review 6.  Traditional Chinese medicine promotes bone regeneration in bone tissue engineering.

Authors:  Zheng-Rong Gao; Yun-Zhi Feng; Ya-Qiong Zhao; Jie Zhao; Ying-Hui Zhou; Qin Ye; Yun Chen; Li Tan; Shao-Hui Zhang; Yao Feng; Jing Hu; Ze-Yue Ou-Yang; Marie Aimee Dusenge; Yue Guo
Journal:  Chin Med       Date:  2022-07-20       Impact factor: 4.546

Review 7.  Current state and challenges in developing oral vaccines.

Authors:  Julia E Vela Ramirez; Lindsey A Sharpe; Nicholas A Peppas
Journal:  Adv Drug Deliv Rev       Date:  2017-04-22       Impact factor: 15.470

Review 8.  Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes.

Authors:  Marta Pelay-Gimeno; Adrian Glas; Oliver Koch; Tom N Grossmann
Journal:  Angew Chem Int Ed Engl       Date:  2015-06-26       Impact factor: 15.336

9.  Glucose- and temperature-sensitive nanoparticles for insulin delivery.

Authors:  Jun-Zi Wu; Gareth R Williams; He-Yu Li; Dongxiu Wang; Huanling Wu; Shu-De Li; Li-Min Zhu
Journal:  Int J Nanomedicine       Date:  2017-05-29

10.  Quality by Design Approach for the Development of Liposome Carrying Ghrelin for Intranasal Administration.

Authors:  Cecília de Barros; Norberto Aranha; Patrícia Severino; Eliana B Souto; Aleksandra Zielińska; André Lopes; Alessandra Rios; Fernando Batain; Kessi Crescencio; Marco Chaud; Thais Alves
Journal:  Pharmaceutics       Date:  2021-05-10       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.